Here are five things to know about Xenco Medical CEO Jason Haider.
Spinal Tech
The global thoracolumbar spine devices market is anticipated to grow at a 6.5 percent compound annual growth rate through 2023, according to a Market Research Future report.
Stryker CEO Kevin Lobo's total compensation reached just over $14 million in 2017.
The global spinal implants market is expected to see rapid growth in the near future, according to Medgadget.
DePuy Synthes alleged Globus Medical engaged in "unlawful tactics," according to Law 360.
LinkedIn ranks Stryker No. 30 on Top Companies 2018 list, ahead of NBA, WeWork and Johnson & Johnson
Both Stryker and Johnson & Johnson appeared on LinkedIn's "Top Companies 2018: Where the U.S. wants to work now" list.
Smith & Nephew chose its Fort Worth, Texas manufacturing plant as the location for a $29 million expansion project, according to the Dallas Business Journal.
Johnson & Johnson CFO Dominic Caruso plans to retire in September, according to The Wall Street Journal.
Here are eight key notes on orthopedic and spine device companies from the past week.
Exactech received FDA 510(k) clearance to market the Novation XLE Vitamin E acetabular polyethylene liners for hip replacement surgery.
